Amanda Grimes
Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amanda Grimes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:28 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03939637 · Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in ChildrenBaylor College of Medicine · completed · Immune Thrombocytopenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:28 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Prospective, randomized study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week.Infect Control Hosp Epidemiol · 199657 citationsRCR 2.3
- Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis.Obstet Gynecol · 200845 citationsRCR 1.9
- 35 citationsRCR 7.3
- Barriers to symptom management care pathway implementation in pediatric Cancer.BMC Health Serv Res · 202116 citationsRCR 1.1
- The effects of technology use in feedlot production systems on feedlot performance and carcass characteristics.J Anim Sci · 201513 citationsRCR 1.0
- Symptom management care pathway adaptation process and specific adaptation decisions.BMC Cancer · 202310 citationsRCR 1.4
- Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.Am J Hematol · 20198 citationsRCR 0.5
- The cost of a "benign" condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropenia.Pediatr Blood Cancer · 20207 citationsRCR 0.5
- 7 citationsRCR 2.2
- Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders.Pediatr Blood Cancer · 20186 citationsRCR 0.2